Presentation + Paper
30 September 2024 SERS-based biosensors for application in biomedicine
Author Affiliations +
Abstract
This work underscores the advancements in Surface-enhanced Raman scattering (SERS) technology, particularly in biomedicine. Known for its high sensitivity and resolution, SERS is a powerful tool for detecting low-concentration analytes. The study focuses on SERS-based nanosensors applied to imaging, biochemical monitoring, diagnostics, and therapy. By combining Raman spectroscopy with SERS, the research achieves precise HER2 quantification in breast cancer cells at the single-cell level, offering insights into cancer heterogeneity and supporting personalized treatments. Additionally, SERS is used to monitor Galunisertib delivery within living colorectal cancer cells, using diatomite-based nanovectors with gold nanoparticles and a pH-sensitive gelatin coating. This setup allows for controlled drug release in response to the tumor microenvironment, with real-time, label-free quantification of Galunisertib at very low concentrations. These findings highlight the potential of SERS to improve the precision and effectiveness of drug delivery and cancer treatment strategies.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Anna Chiara De Luca "SERS-based biosensors for application in biomedicine", Proc. SPIE 13126, Molecular and Nanophotonic Machines, Devices, and Applications VII, 1312603 (30 September 2024); https://doi.org/10.1117/12.3027925
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Surface enhanced Raman spectroscopy

Raman spectroscopy

Gold nanoparticles

Cancer

Cancer detection

Oncology

Tumors

Back to Top